Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PANcreatic Cancer lOcalized Disease in Frail or Elderly Patients Unfit for Both Chemotherapy and Surgery Treated With Stereotactic Ablative Radiotherapy (PANCOSAR): a Multicenter Randomized Controlled Trial

NCT05265663 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT05265663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05265663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PANcreatic Cancer lOcalized Disease in Frail or Elderly Patients Unfit for Both Chemotherapy and Surgery Treated With Stereotactic Ablative Radiotherapy (PANCOSAR): a Multicenter Randomized Controlled Trial
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Not applicable
Overall status
Unknown status
Start date
October 13, 2020
Completion date
June 1, 2024
Enrollment
98 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer non-resectable